{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:44:50Z","timestamp":1759333490840},"reference-count":36,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T00:00:00Z","timestamp":1124668800000},"content-version":"vor","delay-in-days":1421,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Cancer Research"],"published-print":{"date-parts":[[2001,10]]},"abstract":"<jats:p>Natural killer (NK) cell neoplasms, which are derived from mature or precursor NK cells, are rare diseases and are observed predominantly in Asian countries. We analyzed the status of the <jats:italic>Rb, p53, p15INK4B, p16INK4A<\/jats:italic> and <jats:italic>p14ARF<\/jats:italic> genes in these diseases by Southern blot, polymerase chain reaction\u2013single strand conformational polymorphism (PCR\u2013SSCP) and western blot analysis. We used 31 NK cell neoplasms, including four cell lines derived from NK cell neoplasms, 3 myeloid\/ NK cell precursor acute leukemias, 4 blastic NK cell lymphoma\/leukemias, 4 aggressive NK cell leukemia\/lymphomas, 4 nasal NK cell lymphomas, and 12 chronic NK lymphocytosis. We found gene amplification of the <jats:italic>p53<\/jats:italic> gene in one nasal NK cell lymphoma, and point mutations of the <jats:italic>p53<\/jats:italic> gene in one blastic NK cell lymphoma\/leukemia and one chronic NK lymphocytosis. In addition, homozygous deletions of<jats:italic>pl5,p16<\/jats:italic> and<jats:italic>p14<\/jats:italic> genes in 5 out of 31 samples were detected; 3 were from nasal NK cell lymphoma and 2 from blastic NK cell lymphoma\/leukemia. Also hemizygous deletion of the <jats:italic>Kb<\/jats:italic> gene in one blastic NK cell lymphoma was detected. Rb proteins were highly expressed in one cell line as well as two myeloid\/NK cell precursor acute leukemias. In other cell lines, complete loss and an aberrant migration pattern of Rb protein expression were observed. Comparative genomic hybridization suggested that the homozygous deletions of the <jats:italic>p15, p16<\/jats:italic> and <jats:italic>p14<\/jats:italic> were subtle chromosomal deletions and could not be identified by standard karyotyping in some cases. Although the number of cases we analyzed was not large, alterations identified in the <jats:italic>Rb, p53, p16, p15<\/jats:italic> and <jats:italic>p14<\/jats:italic> genes are of significance and might be associated with tumorigenesis in NK cell neoplasms<\/jats:p>","DOI":"10.1111\/j.1349-7006.2001.tb01059.x","type":"journal-article","created":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T11:31:22Z","timestamp":1124710282000},"page":"1048-1056","source":"Crossref","is-referenced-by-count":23,"title":["Molecular Analysis of Tumor Suppressor Genes, Rb, p53,pl6INK4A, pl5INK4B and p14ARF in Natural Killer Cell Neoplasms"],"prefix":"10.1111","volume":"92","author":[{"given":"Sakura","family":"Sakajiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Oshimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,22]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0925-5710(96)00450-1"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2417"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199710000-00014"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.12.3835"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02615.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830490308"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1182\/blood.V89.8.2966","article-title":"CD3\u2013CD56+ non\u2013Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance","volume":"89","author":"Drenou B.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809050908"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05303.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<332::AID-IJC5>3.0.CO;2-0"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2000.7625"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909050949"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3223139.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65454-5"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1905840"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood.V84.8.2412.2412","article-title":"p53 in hemato\u2013logic malignancies","volume":"84","author":"Imamura J.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5293.1672"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780055"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood.V86.3.841.841","article-title":"Role of the cyclin\u2013depen\u2013dent kinase inhibitors in the development of cancer","volume":"86","author":"Hirama T.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.12.1501"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(99)00038-6"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/26.15.3453"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood.V86.4.1548.bloodjournal8641548","article-title":"Loss of the cyclin\u2013dependent kinase 4\u2013inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies","volume":"86","author":"Ogawa S.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_26_2","first-page":"172","article-title":"The genetics of retinoblastoma","volume":"37","author":"Stahl A.","year":"1994","journal-title":"Ann. Genet"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb17453.x"},{"key":"e_1_2_1_28_2","first-page":"437","article-title":"The nuclear oncoproteins: RB and p53","volume":"1","author":"Cowell J. K.","year":"1990","journal-title":"Semin. Cancer Biol."},{"key":"e_1_2_1_29_2","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1182\/blood.V87.12.4949.bloodjournal87124949","article-title":"Inactivation of multiple tumor\u2013suppressor genes involved in negative regulation of the cell cycle, MTSl\/pl6INK4A\/CDKN2, MTS2\/pl5INK4B, p53, and Rb genes in primary lymphoid malignancies","volume":"87","author":"Hangaishi A.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/sj.leu.2401778","article-title":"Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia\u2013lymphoma","volume":"14","author":"Drexler H. G.","year":"2000","journal-title":"Leukemia"},{"key":"e_1_2_1_31_2","volume-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook J.","year":"1989"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8153634"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/368753a0"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.V79.2.477.477","article-title":"Mutations of the p53 gene in adult T\u2013cell leukemia","volume":"79","author":"Sakashita A.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(99)90147-8"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1380020503"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-199803000-00024"}],"container-title":["Japanese Journal of Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2001.tb01059.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2001.tb01059.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T13:59:52Z","timestamp":1700402392000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2001.tb01059.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["10.1111\/j.1349-7006.2001.tb01059.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2001.tb01059.x","archive":["Portico"],"relation":{},"ISSN":["0910-5050"],"issn-type":[{"value":"0910-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}